InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,531.55
(
0.92%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
-1.49%
)
Bitcoin
69,468.71
(
-1.05%
)
Post# of 409
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mopar44o

Send PM Follow Ignore
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

mopar44o

Re: None

Monday, 03/26/2018 6:18:46 PM

Monday, March 26, 2018 6:18:46 PM

Post# of 409
Hey guys quick question, might sound stupid even.

With MNK discontinuing the generic division and selling it. Is it still operating as normal for now until sold? Do they mean they're just not developing / partnering more generics? I can't see them getting any buyers by just shutting it down. What's really the process here? Just curious because I own shares in a more jr pharma that partnered several a generics with MNK and the sales results have been less than impressive.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up